{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:12:54Z","timestamp":1780085574184,"version":"3.54.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12350-015-0234-0","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T18:09:07Z","timestamp":1440094147000},"page":"560-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Wael","family":"AlJaroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Campagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtihaj","family":"Fughhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Wassouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Doukky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-015-0234-0_bib1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.CIR.0000080946.42225.4D","volume":"108","author":"Klocke","year":"2003","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0234-0_bib2","unstructured":"AMR\/Arlington Medical Resources Inc. Myocardial Study Market Guide, Jan to Jun 2012; 2012."},{"key":"10.1007\/s12350-015-0234-0_bib3","unstructured":"Astellas Pharma US. Lexiscan. 2015. www.lexiscan.com. Accessed 6 July 2015."},{"key":"10.1007\/s12350-015-0234-0_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.105.095323","article-title":"Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats","volume":"316","author":"Dhalla","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s12350-015-0234-0_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ahj.2009.01.011","article-title":"Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus","volume":"157","author":"Hage","year":"2009","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0234-0_bib6","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000072770.27332.75","article-title":"Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study","volume":"107","author":"Abidov","year":"2003","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0234-0_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jacc.2004.08.069","article-title":"A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy","volume":"45","author":"Hachamovitch","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12350-010-9242-2","article-title":"Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging","volume":"17","author":"Mathur","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2009.01.007","article-title":"Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease","volume":"103","author":"Venkataraman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjcard.2012.09.013","article-title":"Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress","volume":"111","author":"Iqbal","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2011.05.014","article-title":"The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease","volume":"162","author":"Hage","year":"2011","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0234-0_bib12","first-page":"1159","article-title":"Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms","volume":"95","author":"Bhatheja","year":"2005","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0234-0_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12350-012-9654-2","article-title":"Morales Demori R. The safety and tolerability of regadenoson in patients with end-stage renal disease: The first prospective evaluation","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjcard.2009.08.663","article-title":"Safety of regadenoson in patients with end-stage renal disease","volume":"105","author":"Aljaroudi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib15","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0234-0_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ndt\/gfm634","article-title":"Heart rate variability (HRV) in kidney failure: Measurement and consequences of reduced HRV","volume":"23","author":"Ranpuria","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"10.1007\/s12350-015-0234-0_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12350-012-9533-x","article-title":"Attenuation of the side effect profile of regadenoson: A randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging \u201cThe ASSUAGE trial\u201d","volume":"19","author":"Doukky","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10554-012-0166-6","article-title":"Attenuation of the side effect profile of regadenoson: A randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease\u2014the ASSUAGE-CKD trial","volume":"29","author":"Doukky","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1007\/s12350-015-0234-0_bib19","first-page":"1","article-title":"ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers","volume":"2009","author":"Henzlova","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12350-014-9864-x","article-title":"The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: A substudy of the ASSUAGE trial","volume":"21","author":"Ballany","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12350-015-0087-6","article-title":"The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT","volume":"22","author":"Golzar","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12350-013-9765-4","article-title":"The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: A cautionary note in patients with diabetes and coronary artery disease","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s12350-011-9429-1","article-title":"A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging","volume":"18","author":"Hage","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-014-0050-y","article-title":"The prognostic value of regadenoson myocardial perfusion imaging","author":"Hage","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib25","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/eurheartj\/ehr031","article-title":"An overview of the objectives of and the approaches to propensity score analyses","volume":"32","author":"Heinze","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-015-0234-0_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12350-013-9820-1","article-title":"Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET","volume":"21","author":"Bellam","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib27","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.ijcard.2012.08.011","article-title":"The heart rate response to adenosine: A simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes","volume":"167","author":"Hage","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12350-014-9997-y","article-title":"Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation","volume":"22","author":"Parikh","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s12350-014-9886-4","article-title":"The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease","volume":"21","author":"Aggarwal","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s12350-010-9271-x","article-title":"Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease","volume":"17","author":"AlJaroudi","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0234-0_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.amjcard.2010.05.039","article-title":"Left ventricular mechanical dyssynchrony by phase analysis of gated single photon emission computed tomography in end-stage renal disease","volume":"106","author":"Aljaroudi","year":"2010","journal-title":"Am J Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0234-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-015-0234-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123068460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123068460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0234-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:58:41Z","timestamp":1761026321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123068460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1071358123068460"],"URL":"https:\/\/doi.org\/10.1007\/s12350-015-0234-0","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-015-0234-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}